SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-16-001258
Filing Date
2016-11-16
Accepted
2016-11-16 13:17:35
Documents
48
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 bivi-20160930_10q.htm 10-Q 226963
2 EXHIBIT 31.1 bivi-20160930_10qex31z1.htm EX-31.1 12111
3 EXHIBIT 32.1 bivi-20160930_10qex32z1.htm EX-32.1 5805
  Complete submission text file 0001520138-16-001258.txt   1499884

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bivi-20160930.xml EX-101.INS 196206
5 XBRL CALCULATION FILE bivi-20160930_cal.xml EX-101.CAL 28272
6 XBRL DEFINITION FILE bivi-20160930_def.xml EX-101.DEF 27871
7 XBRL LABEL FILE bivi-20160930_lab.xml EX-101.LAB 159130
8 XBRL PRESENTATION FILE bivi-20160930_pre.xml EX-101.PRE 116922
9 XBRL SCHEMA FILE bivi-20160930.xsd EX-101.SCH 21825
Mailing Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915
Business Address 100 CUMMINGS CENTER, SUITE 247-C BEVERLY MA 01915 312-283-5793
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

IRS No.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-55292 | Film No.: 162001969
SIC: 2834 Pharmaceutical Preparations